S.C. IMUNOTEHNOMED S.R.L.   Report issue

For profit Phase 3
Founded: Chisinau Moldova, Republic of (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2019
NCT04093518
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

S.C. IMUNOTEHNOMED S.R.L.